Why Moderna Shares Jumped 6% on Tuesday

Benzinga2022-03-23

Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.

Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.

Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.

MRNA 52-Week Range:$117.34 - $497.49

Moderna Shares closed higher 6.47% at $186.72.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

159

Report

Comment（13）

339742f5
·2022-03-23
Should i buy moderna share?
Reply
2
Report
KeN3
·2022-03-23
Prices down for the others though
Reply
2
Report
yeo
·2022-03-23
Stay out medical. Short squeeze
Reply
3
Report
Thomas9413
·2022-03-23
Great
Reply
4
Report
ALIBINHASSAN
·2022-03-23
I love Moderna
Reply
4
Report
Bull_Horn
·2022-03-23
👍
Reply
4
Report
LWKJKK
·2022-03-23
Good to know this will continue to increase
Reply
4
Report
StarGate
·2022-03-23
Good news...
Reply
3
Report
ThinkOrSwim
·2022-03-23
The CEO has cashed out 400 million buckeroos, and u think it has upside? Let it go.
Reply
4
Report
Rocket2ocean
·2022-03-23
Go go go! Like pls!!
Reply
3
Report
SalTheFun
·2022-03-23
Long way still to reach the same height
Reply
4
Report
XLMM
·2022-03-23
aim for $5xx! haut ah!
Reply
4
Report
Ahsiang
·2022-03-23
Chiong arrrrrrrrrrrr
Reply
4
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1146279280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-23 11:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146279280","market":"us","top_or_hot":-1,"title":"Why Moderna Shares Jumped 6% on Tuesday","media":"Benzinga","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n2022-03-23 11:39 北京时间&nbsp;&nbsp;&nbsp;<strong>Benzinga</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1146279280","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","pubTimestamp":1648006778,"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"为什么Moderna股价周二上涨6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9037321170,"gmtCreate":1648036178860,"gmtModify":1676534295313,"author":{"id":"4108913771261690","authorId":"4108913771261690","name":"339742f5","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4108913771261690","authorIdStr":"4108913771261690"},"htmlText":"Should i buy moderna share?","listText":"Should i buy moderna share?","text":"Should i buy moderna share?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037321170","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037972139,"gmtCreate":1648016228980,"gmtModify":1676534293458,"author":{"id":"4090570965971460","authorId":"4090570965971460","name":"KeN3","avatar":"https://static.tigerbbs.com/ffc770a2d3626a3e029ba2c461aac13d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4090570965971460","authorIdStr":"4090570965971460"},"htmlText":"Prices down for the others though","listText":"Prices down for the others though","text":"Prices down for the others though","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037972139","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037946501,"gmtCreate":1648013828530,"gmtModify":1676534293202,"author":{"id":"3558440698099291","authorId":"3558440698099291","name":"yeo","avatar":"https://static.tigerbbs.com/f2ac157a0de74e3fac334b84c7779a75","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":0,"idStr":"3558440698099291","authorIdStr":"3558440698099291"},"htmlText":"Stay out medical. Short squeeze&nbsp;","listText":"Stay out medical. Short squeeze&nbsp;","text":"Stay out medical. Short squeeze","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037946501","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037952818,"gmtCreate":1648011921553,"gmtModify":1676534292900,"author":{"id":"3585385605908328","authorId":"3585385605908328","name":"Thomas9413","avatar":"https://static.tigerbbs.com/effcfaa82ddb11a4fa57136b2a6f8351","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":1,"crmLevelSwitch":0,"idStr":"3585385605908328","authorIdStr":"3585385605908328"},"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037952818","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037956719,"gmtCreate":1648011786196,"gmtModify":1676534292891,"author":{"id":"3570479349727470","authorId":"3570479349727470","name":"ALIBINHASSAN","avatar":"https://static.tigerbbs.com/1a7c31b79e7bff28841c5f18dca737f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570479349727470","authorIdStr":"3570479349727470"},"htmlText":"I love Moderna","listText":"I love Moderna","text":"I love Moderna","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037956719","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037951187,"gmtCreate":1648011321955,"gmtModify":1676534292827,"author":{"id":"4089002214432400","authorId":"4089002214432400","name":"Bull_Horn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4089002214432400","authorIdStr":"4089002214432400"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037951187","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037924419,"gmtCreate":1648010301469,"gmtModify":1676534292713,"author":{"id":"4096337009824130","authorId":"4096337009824130","name":"LWKJKK","avatar":"https://static.tigerbbs.com/c8865fe58cb1e2421bb5f60a39a8af3e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4096337009824130","authorIdStr":"4096337009824130"},"htmlText":"Good to know this will continue to increase","listText":"Good to know this will continue to increase","text":"Good to know this will continue to increase","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037924419","repostId":1146279280,"repostType":2,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037929230,"gmtCreate":1648008761449,"gmtModify":1676534292548,"author":{"id":"3586990023332519","authorId":"3586990023332519","name":"StarGate","avatar":"https://static.tigerbbs.com/9db084b2eae373a6cc56043329defb07","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586990023332519","authorIdStr":"3586990023332519"},"htmlText":"Good news...","listText":"Good news...","text":"Good news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037929230","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037964649,"gmtCreate":1648008220107,"gmtModify":1676534292483,"author":{"id":"4107161170881400","authorId":"4107161170881400","name":"ThinkOrSwim","avatar":"https://static.itradeup.com/news/456b9d740a0500cd2e7af1a1332c61de","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4107161170881400","authorIdStr":"4107161170881400"},"htmlText":"The CEO has cashed out 400 million buckeroos, and u think it has upside? Let it go.","listText":"The CEO has cashed out 400 million buckeroos, and u think it has upside? Let it go.","text":"The CEO has cashed out 400 million buckeroos, and u think it has upside? Let it go.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037964649","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037966399,"gmtCreate":1648007546462,"gmtModify":1676534292416,"author":{"id":"3573564985836603","authorId":"3573564985836603","name":"Rocket2ocean","avatar":"https://static.tigerbbs.com/871ff8b7f4e7fb157bec1151aefa3930","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3573564985836603","authorIdStr":"3573564985836603"},"htmlText":"Go go go! Like pls!!&nbsp;","listText":"Go go go! Like pls!!&nbsp;","text":"Go go go! Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037966399","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037968294,"gmtCreate":1648007388677,"gmtModify":1676534292388,"author":{"id":"3579809773434763","authorId":"3579809773434763","name":"SalTheFun","avatar":"https://static.tigerbbs.com/69c72146aa04d3efddd999f936505379","vip":1,"crmLevel":8,"crmLevelSwitch":1,"idStr":"3579809773434763","authorIdStr":"3579809773434763"},"htmlText":"Long way still to reach the same height","listText":"Long way still to reach the same height","text":"Long way still to reach the same height","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037968294","repostId":1146279280,"repostType":2,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037968834,"gmtCreate":1648007362749,"gmtModify":1676534292377,"author":{"id":"4100909250192760","authorId":"4100909250192760","name":"XLMM","avatar":"https://community-static.tradeup.com/news/5fd3a75ea7ccf88aca493e34c270e676","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":1,"crmLevelSwitch":0,"idStr":"4100909250192760","authorIdStr":"4100909250192760"},"htmlText":"aim for $5xx! haut ah!","listText":"aim for $5xx! haut ah!","text":"aim for $5xx! haut ah!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037968834","repostId":1146279280,"repostType":2,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9037961139,"gmtCreate":1648007163374,"gmtModify":1676534292357,"author":{"id":"3582617881962608","authorId":"3582617881962608","name":"Ahsiang","avatar":"https://static.tigerbbs.com/310f96e7696af85ae33ece774a483d15","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3582617881962608","authorIdStr":"3582617881962608"},"htmlText":"Chiong arrrrrrrrrrrr","listText":"Chiong arrrrrrrrrrrr","text":"Chiong arrrrrrrrrrrr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037961139","repostId":1146279280,"repostType":4,"repost":{"id":"1146279280","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648006778,"share":"https://ttm.financial/m/news/1146279280?lang=&edition=fundamental","pubTime":"2022-03-23 11:39","market":"us","language":"en","title":"Why Moderna Shares Jumped 6% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1146279280","media":"Benzinga","summary":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate devel","content":"<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Shares Jumped 6% on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Shares Jumped 6% on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-23 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Moderna Inc</b> shares traded higher Tuesday after the company announced two new vaccine candidate developments.</p><p>Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.</p><p>Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.</p><p><b>MRNA 52-Week Range:</b>$117.34 - $497.49</p><p>Moderna Shares closed higher 6.47% at $186.72.</p><p><img src=\"https://static.tigerbbs.com/392b15109df25257b7215a461b1ac6de\" tg-width=\"840\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146279280","content_text":"Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.MRNA 52-Week Range:$117.34 - $497.49Moderna Shares closed higher 6.47% at $186.72.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":159,"commentSize":13,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}